OCAI
UTHR icon

O'Connor Alternative Investments’s United Therapeutics UTHR Stock Holding History

O'Connor Alternative Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
+2,700
New +$1.52M 0.11% 94

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

O'Connor Alternative Investments's UTHR Position: Q2 2026 in Review

O'Connor Alternative Investments opened a new position in United Therapeutics (UTHR) in Q2 2026: 2,700 shares worth $1.46M. The stake represents 0.11% of the portfolio and ranks #94 among its holdings.

818 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • O'Connor Alternative Investments held 2,700 shares of United Therapeutics worth $1.46M as of Q2 2026.
  • United Therapeutics was a new O'Connor Alternative Investments position in Q2 2026.
  • United Therapeutics made up 0.11% of O'Connor Alternative Investments's portfolio in Q2 2026, its #94 holding.
  • 818 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on O'Connor Alternative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.